2024 Q3 Form 10-Q Financial Statement

#000165495424010649 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $291.2K $490.6K
YoY Change -4.15% 45.37%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $419.9K $398.1K
YoY Change -0.36% -24.89%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $419.8K $398.1K
YoY Change -0.36% -30.17%
Operating Profit
YoY Change
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $589.3K $547.7K
YoY Change 92.6% 52.13%
Income Tax $125.5K $134.7K
% Of Pretax Income 21.3% 24.6%
Net Earnings $463.8K $412.9K
YoY Change 25.5% 489.91%
Net Earnings / Revenue 159.28% 84.18%
Basic Earnings Per Share $0.07 $0.06
Diluted Earnings Per Share $0.07 $0.06
COMMON SHARES
Basic Shares Outstanding 6.385M shares 6.385M shares
Diluted Shares Outstanding 6.502M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.133M $5.425M
YoY Change 225.37% 393.15%
Cash & Equivalents $3.133M $5.425M
Short-Term Investments
Other Short-Term Assets $67.64K $103.8K
YoY Change -68.89% -35.15%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.353M $5.956M
YoY Change 103.28% 227.26%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00
YoY Change -100.0% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $492.2K
YoY Change -60.89%
Other Assets $779.0K $772.0K
YoY Change 96.22% 79.53%
Total Long-Term Assets $16.99M $13.70M
YoY Change -5.46% -19.22%
TOTAL ASSETS
Total Short-Term Assets $3.353M $5.956M
Total Long-Term Assets $16.99M $13.70M
Total Assets $20.34M $19.66M
YoY Change 3.69% 4.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $111.2K $87.64K
YoY Change -10.4% 9.55%
Accrued Expenses $317.8K $185.2K
YoY Change 2059.1% 1752.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $429.0K $272.8K
YoY Change 209.08% 203.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $62.00K
YoY Change
Total Long-Term Liabilities $62.00K $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $429.0K $272.8K
Total Long-Term Liabilities $62.00K $0.00
Total Liabilities $491.0K $272.8K
YoY Change 253.75% 180.92%
SHAREHOLDERS EQUITY
Retained Earnings -$1.160M -$1.160M
YoY Change 0.0% 0.0%
Common Stock $6.385K $1.467M
YoY Change -99.57% -0.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.85M $19.39M
YoY Change
Total Liabilities & Shareholders Equity $20.34M $19.66M
YoY Change 3.69% 4.67%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $463.8K $412.9K
YoY Change 25.5% 489.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$2.292M $4.920M
YoY Change 308.67% 44.28%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -2.292M 4.920M
Cash From Investing Activities
Cash From Financing Activities 0.000 0.000
Net Change In Cash -2.292M 4.920M
YoY Change 1575.49% 645.44%
FREE CASH FLOW
Cash From Operating Activities -$2.292M $4.920M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
300000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001425355
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
111111111 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6385255 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6385255 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41472
dei Entity Registrant Name
EntityRegistrantName
MILL CITY VENTURES III, LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0316651
dei Entity Address Address Line1
EntityAddressAddressLine1
1907 Wayzata Blvd, #205
dei Entity Address City Or Town
EntityAddressCityOrTown
Wayzata
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55391
dei City Area Code
CityAreaCode
952
dei Local Phone Number
LocalPhoneNumber
479-1923
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6385255 shares
CY2024Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
12929985 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
17284676 usd
CY2024Q2 mcvt Non Control Non Affiliate Investment At Cost
NonControlNonAffiliateInvestmentAtCost
14460679 usd
CY2023Q4 mcvt Non Control Non Affiliate Investment At Cost
NonControlNonAffiliateInvestmentAtCost
18577481 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5424611 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
376024 usd
CY2024Q2 us-gaap Notes Receivable Net
NotesReceivableNet
250000 usd
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
250000 usd
CY2024Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
103762 usd
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
165301 usd
CY2024Q2 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
177792 usd
CY2023Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
264413 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9283 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
772000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
757000 usd
CY2024Q2 us-gaap Assets
Assets
19658150 usd
CY2023Q4 us-gaap Assets
Assets
19106697 usd
CY2024Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
87644 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
71702 usd
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7604 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
435449 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
0 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
9283 usd
CY2024Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
177600 usd
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
0 usd
CY2024Q2 us-gaap Liabilities
Liabilities
272848 usd
CY2023Q4 us-gaap Liabilities
Liabilities
516434 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
111111111 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
6385 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6385 usd
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6385255 shares
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15473121 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15473121 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1460209 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1460209 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1159665 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1159665 usd
CY2024Q2 mcvt Accumulated Other Comprehensive Income Loss Undistributed Investment Loss
AccumulatedOtherComprehensiveIncomeLossUndistributedInvestmentLoss
-390494 usd
CY2023Q4 mcvt Accumulated Other Comprehensive Income Loss Undistributed Investment Loss
AccumulatedOtherComprehensiveIncomeLossUndistributedInvestmentLoss
-1052183 usd
CY2024Q2 mcvt Accumulated Other Comprehensive Income Loss Undistributed Net Realized Gains Loss On Investment Transactions
AccumulatedOtherComprehensiveIncomeLossUndistributedNetRealizedGainsLossOnInvestmentTransactions
5526440 usd
CY2023Q4 mcvt Accumulated Other Comprehensive Income Loss Undistributed Net Realized Gains Loss On Investment Transactions
AccumulatedOtherComprehensiveIncomeLossUndistributedNetRealizedGainsLossOnInvestmentTransactions
5155200 usd
CY2024Q2 mcvt Stockholders Equity Unrealized Appreciation In Value Of Investments
StockholdersEquityUnrealizedAppreciationInValueOfInvestments
-1530694 usd
CY2023Q4 mcvt Stockholders Equity Unrealized Appreciation In Value Of Investments
StockholdersEquityUnrealizedAppreciationInValueOfInvestments
-1292804 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
19385302 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18590263 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19658150 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19106697 usd
CY2024Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
3.04
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
2.91
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
888629 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
907502 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1721296 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1771530 usd
CY2024Q2 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
888629 usd
CY2023Q2 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
907502 usd
us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
1721296 usd
us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
1771530 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
174098 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
287325 usd
us-gaap Professional Fees
ProfessionalFees
312469 usd
us-gaap Professional Fees
ProfessionalFees
417176 usd
CY2024Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
145859 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
147161 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
296925 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1277600 usd
CY2024Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
24602 usd
CY2023Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
26522 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
51492 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
53522 usd
CY2024Q2 us-gaap Occupancy Net
OccupancyNet
9545 usd
CY2023Q2 us-gaap Occupancy Net
OccupancyNet
21072 usd
us-gaap Occupancy Net
OccupancyNet
20222 usd
us-gaap Occupancy Net
OccupancyNet
40115 usd
CY2024Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
30000 usd
CY2023Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
30000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
60000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
562968 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
43333 usd
us-gaap Interest Expense
InterestExpense
320 usd
us-gaap Interest Expense
InterestExpense
78000 usd
CY2024Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
13955 usd
CY2023Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
14632 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
17718 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
32481 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
398059 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
570045 usd
us-gaap Operating Expenses
OperatingExpenses
759146 usd
us-gaap Operating Expenses
OperatingExpenses
2461862 usd
CY2024Q2 us-gaap Net Investment Income
NetInvestmentIncome
490570 usd
CY2023Q2 us-gaap Net Investment Income
NetInvestmentIncome
337457 usd
us-gaap Net Investment Income
NetInvestmentIncome
962150 usd
us-gaap Net Investment Income
NetInvestmentIncome
-690332 usd
CY2024Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
346745 usd
CY2023Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
41371 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
371240 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-558629 usd
CY2024Q2 mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-289641 usd
CY2023Q2 mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-21107 usd
mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-237890 usd
mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
627316 usd
CY2024Q2 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
57104 usd
CY2023Q2 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
20264 usd
us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
133350 usd
us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
68687 usd
CY2024Q2 mcvt Investment Company Net Assets From Operation Increase Decrease
InvestmentCompanyNetAssetsFromOperationIncreaseDecrease
547674 usd
CY2023Q2 mcvt Investment Company Net Assets From Operation Increase Decrease
InvestmentCompanyNetAssetsFromOperationIncreaseDecrease
357721 usd
mcvt Investment Company Net Assets From Operation Increase Decrease
InvestmentCompanyNetAssetsFromOperationIncreaseDecrease
1095500 usd
mcvt Investment Company Net Assets From Operation Increase Decrease
InvestmentCompanyNetAssetsFromOperationIncreaseDecrease
-621645 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
134738 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
287000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300461 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25678 usd
CY2024Q2 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
412936 usd
CY2023Q2 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
70721 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
795039 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-647323 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
18972366 usd
CY2024Q2 us-gaap Investment Income Net
InvestmentIncomeNet
355832 usd
CY2024Q2 mcvt Undistributed Net Realized Gain On Investment Transactions
UndistributedNetRealizedGainOnInvestmentTransactions
346745 usd
CY2024Q2 mcvt Depreciation In Value Of Investments
DepreciationInValueOfInvestments
-289641 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
19385302 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
18613725 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
50457 usd
CY2023Q2 mcvt Undistributed Net Realized Gain On Investment Transactions
UndistributedNetRealizedGainOnInvestmentTransactions
41371 usd
CY2023Q2 mcvt Depreciation In Value Of Investments
DepreciationInValueOfInvestments
-21107 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18684446 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
18590263 usd
us-gaap Investment Income Net
InvestmentIncomeNet
661689 usd
mcvt Undistributed Net Realized Gain On Investment Transactions
UndistributedNetRealizedGainOnInvestmentTransactions
371240 usd
mcvt Depreciation In Value Of Investments
DepreciationInValueOfInvestments
-237890 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
19385302 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17871560 usd
mcvt Stock Options Issued
StockOptionsIssued
1460209 usd
mcvt Net Investment Loss
NetInvestmentLoss
-716010 usd
mcvt Undistributed Net Realized Loss On Investment Transactions
UndistributedNetRealizedLossOnInvestmentTransactions
-558629 usd
mcvt Appreciation In Value Of Investments
AppreciationInValueOfInvestments
627316 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18684446 usd
mcvt Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
795039 usd
mcvt Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
-647323 usd
mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-237890 usd
mcvt Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
627316 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
371240 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-558629 usd
mcvt Purchases Of Investments
PurchasesOfInvestments
973438 usd
mcvt Purchases Of Investments
PurchasesOfInvestments
8900500 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
5461479 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
9149194 usd
mcvt Issuance Of Stock Options
IssuanceOfStockOptions
0 usd
mcvt Issuance Of Stock Options
IssuanceOfStockOptions
1460209 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-15000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-227000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-70822 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-70516 usd
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-86621 usd
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
58420 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-243586 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-710228 usd
mcvt Increase Decrease In Deferred Interest Income
IncreaseDecreaseInDeferredInterestIncome
0 usd
mcvt Increase Decrease In Deferred Interest Income
IncreaseDecreaseInDeferredInterestIncome
55875 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5048587 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11886 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2750000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
2750000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5048587 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
11886 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
376024 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1089641 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5424611 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1101527 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1438 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Use of estimates: </em></strong>The preparation of financial statements in conformity with GAAP requires management and our independent board members to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. For more information, see the “Valuation of portfolio investments” caption below, and “Note 4 – Fair Value of Financial Instruments” below. The Company presents its financial statements as an investment company following accounting and reporting guidance in ASC 946.</p>
CY2024Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
14460679 usd
mcvt Investment And Loans Amortized Cost
InvestmentAndLoansAmortizedCost
1 pure
CY2024Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
12929985 usd
mcvt Investment And Loan Percentage Of Fair Value
InvestmentAndLoanPercentageOfFairValue
1 pure
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
18577481 usd
CY2023 mcvt Investment And Loans Amortized Cost
InvestmentAndLoansAmortizedCost
1 pure
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
17284676 usd
CY2023 mcvt Investment And Loan Percentage Of Fair Value
InvestmentAndLoanPercentageOfFairValue
1 pure
CY2023 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
25700 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6385255 shares
mcvt Investment Company Provision For Income Taxes Per Share
InvestmentCompanyProvisionForIncomeTaxesPerShare
-0.04
mcvt Investment Company Provision For Income Taxes Per Share
InvestmentCompanyProvisionForIncomeTaxesPerShare
-0.01
mcvt Investment Company Provision For Income Taxes Per Share
InvestmentCompanyProvisionForIncomeTaxesPerShare
-0.04
mcvt Investment Company Provision For Income Taxes Per Share
InvestmentCompanyProvisionForIncomeTaxesPerShare
-0.09
mcvt Investment Company Provision For Income Taxes Per Share
InvestmentCompanyProvisionForIncomeTaxesPerShare
0.00
mcvt Investmentcompanyissuance Of Stock Options
InvestmentcompanyissuanceOfStockOptions
0.00
mcvt Investmentcompanyissuance Of Stock Options
InvestmentcompanyissuanceOfStockOptions
0.24
mcvt Investmentcompanyissuance Of Stock Options
InvestmentcompanyissuanceOfStockOptions
0.01
mcvt Investmentcompanyissuance Of Stock Options
InvestmentcompanyissuanceOfStockOptions
0.00
mcvt Investmentcompanyissuance Of Stock Options
InvestmentcompanyissuanceOfStockOptions
0.00
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.00
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.00
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.00
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.00
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.02
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6385255 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6185255 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4808508 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4794744 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4877654 shares
CY2023Q2 mcvt Net Assets At End Of Period
NetAssetsAtEndOfPeriod
0 usd

Files In Submission

Name View Source Status
0001654954-24-010649-index-headers.html Edgar Link pending
0001654954-24-010649-index.html Edgar Link pending
0001654954-24-010649.txt Edgar Link pending
0001654954-24-010649-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mcvt-20240630.xsd Edgar Link pending
mcvt_10q.htm Edgar Link pending
mcvt_ex311.htm Edgar Link pending
mcvt_ex312.htm Edgar Link pending
mcvt_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
mcvt-20240630_cal.xml Edgar Link unprocessable
mcvt-20240630_lab.xml Edgar Link unprocessable
mcvt-20240630_def.xml Edgar Link unprocessable
mcvt-20240630_pre.xml Edgar Link unprocessable
mcvt_10q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable